Reproductive Endocrinology Luteal Phase

Clinical evaluation of luteal function

Nakajima ST, Molloy MH, Oi RH, Ohlson KA, Azevedo RA, Boyers SP

Published August 1994 Obstetrics and Gynecology, 84(2), 219-221
PMID 8041533

Abstract

Objective

To determine the ability of luteal phase length determined by basal body temperature (BBT) pattern and a midluteal serum progesterone level to predict the result of an endometrial biopsy in a subsequent cycle.

Methods

We performed a retrospective analysis of 141 women with a history of infertility who were being evaluated for luteal function. The luteal phase length determined from a BBT chart of one menstrual cycle was compared to a single midluteal serum progesterone level from a second menstrual cycle. These findings were compared to a luteal phase endometrial biopsy performed in a third menstrual cycle. Subjects were divided into four groups depending upon luteal phase length (normal 11 or more days) and serum progesterone level (normal at least 10 ng/mL). The four groups were designated "normal," "short luteal phase," "low progesterone," and "abnormal," depending upon the results of the two tests. The frequency of in- and out-of-phase endometrial biopsy results in the four groups was compared.

Results

There was no difference in the occurrence of an in- or out-of-phase endometrial biopsy when the four groups were compared.

Conclusion

Neither luteal phase length nor a single midluteal serum progesterone level was predictive of subsequent in-phase or out-of-phase endometrial biopsy.

Topics

By this author

Related research

Reproductive Endocrinology › Luteal Phase › Luteal Phase Deficiency · Diagnostics › Cycle Biomarkers › Temperature Tracking · Menstrual Cycle › Cycle Biomarkers › Hormonal Markers
PMID 8041533 8041533 Nakajima et al. 1994, Nakajima 1994